Friday, 1 November 2019

Dental CAD/CAM Market Trends 2019- Industry Analysis By Size, Share, Growth and Regional Forecast



Dental CAD/CAM Market Highlights

CAD/CAM, or computer-aided design and computer-aided manufacturing, refers to a computer-based software that is used for both manufacturing and designing products. In CAD, the computer technology is leveraged upon for design and design documentation. CAM, on the other hand, uses the assemblies and models that are created in CAD software. Following which, it generates tool paths that drives the machines and turns the designs into physical components or parts. In recent years, CAD/CAM have entered into the dental domain to aid in dental practices. The adoption of the technology is ensuring accurate restoration with higher productivity level as compared to dental lab restorations. This technology is aiding dentists across the global significantly by allowing them to customize appliances particularly for patients in such a manner that was not possible beforehand.


The increased satisfaction levels among patients due to advances in dental technology is likely to boost market demand. Since both patients and dentists are getting productive results in a faster manner, CAD/CAM dentistry technology is highly beneficial from both fronts. In the recently released in-depth report by Market Research Future (MRFR), it was mentioned that the global dental CAD/CAM market is increasing at a rapid pace and is projected to grow at an annual rate of 8.1% during the forecast period of 2016 to 2027.
Due to the advent of various technological advancements, disorders and conditions like Sleep Apnea and Sports Mouth Guards to Splints and tools for curing Temporomandibular Joint Disorders are being created for patients to narrow down the accuracy level to a couple of microns. This has further helped dentists to provide patients with better clinical results and experience. The present surge in demand for dental cosmetic surgeries is expected to be one of the biggest drivers of the market in the forthcoming years. The consumer spend on cosmetic dentistry has significantly amplified over the years.
In this, tooth whitening is the most demanded and pursued procedure, while whole tooth-colored inlays, tooth-colored crowns, tooth-colored on lays, veneers, and bonding are some of the other prime and key contributors. The advancement in the healthcare spectrum has helped increase the expectancy of life among the global population. This has, in turn, increasing the population of old-age people around the world. As old-age people are more prone to dental issues, this is likely to push the market demand for computer-aided design as well as computer-aided manufacturing.
However, amidst the positives, a major constraint in relation to the market is the cost associated with the same. Emergence of new and innovative technologies alongside lack of skilled workforce are the major contributing factors responsible for the high pricing nature of CAD/CAM. However, at the same time, expansion in intra-oral scanners and open architecture solutions is believed to foster the overall dental CAD/CAM market. Additionally, increasing awareness concerning health-related issues coupled with the growing adoption of automation technology is bound to lead to the high growth of the computer-aided design and computer-aided manufacturing market in the forthcoming years.
Market Segmentation
The Global Dental CAD/CAM Market segmentation is done on the basis of applications, type of products, region, and end-user.
By type of products product, the market divides into in-office system and in-lab system.
By component, the market includes equipment and software. The equipment segment further divides down into milling machines and scanners and software.
By application, the market comprises crowns, bridges, dentures, veneers, and inlays or onlays.
By region, the market covers North America, Europe, Asia Pacific, and the Middle East and Africa.
By end-user, the market includes dental clinic, dental laboratory, and research or academic institutes.

Competitive Landscape
The Global Dental CAD/CAM market includes a number of prominent players including B&D Dental Technologies, Dentsply Sirona, Align Technology, Inc., Axsys Incorporated, Nobel Biocare (Part of Danaher Corporation), Roland DGA Corporation, Straumann, KaVo Dental GmbH, DATRON AG, 3Shape A/S, Yenadent Ltd, Planmeca OY, and others.


Latest Trending Reports




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Wednesday, 30 October 2019

Biohacking Market: Global Industry Analysis and Opportunity Assessment 2018-2023

Overview:
Experiments in various segments of the healthcare sector have revealed long back that treatments affect each differently. This has given rise to self-monitoring which as a consequence, is also impacting the research & development section of the healthcare industry. This technology is gaining precedence as biohacking or do-it-yourself (DIY) biology, a leap that the synthetic biology is taking to the next level where it can answer a lot of unsolved questions based on readings gathered from a wide array of the source.


The technology is a blend of medical, nutritional, and electronic technique which brings down the cost of research considerably by creating several opportunities to have lab experiments done on a smaller scale, yet with an unwavering focus. The technology includes wearables or chip inserted in the body to monitor various activities taking place inside the body. Its impact on biotechnology, molecular biology, genetic engineering, and other segments are significant. Market Research Future (MRFR) reveals that the market is going to reach to a valuation of USD 25103.13 million by 2023. It is climbing an excellent CAGR of 19.42% during the forecast period (2017-2023).
The comprehensive study of the said market reveals that the prevalence of chronic diseases and advents in technology are going to impact substantially. In the U.S., the American Cancer Association reveals that 13% of the population are diagnosed with cancer before they reach age 20. On the other hand, the American Diabetic Association reveals a daunting 9.3% is suffering from diabetes. These figures are enough to indicate possibilities that the market can have to expand. Advanced technologies are also triggering further growth. Integration of radio frequency identification (RFID) and the inclusion of the internet of things (IoT) is gaining a strong foothold which would considerably inflate the market.
However, the market can see sporadic episodes of bottlenecking. Cybercrimes can put up hurdles by leaking personal documents which can adversely impact the progress. At the same time, remote access to healthcare accessories such as insulin pumps, cochlear implants, and pacemakers, if gone to the wrong hands can have fatal consequences. But gadgets are fast becoming the lifeline of the current generation which in a way, would bring out the market from such a situation.

Competitive Analysis
The market, in the future, can receive a boost from several cross-sections such as animal-free leather, electric DNA control, non-browning apples, DNA printing and other. The change can be quite substantial. Various companies are implementing different strategies to gain mileage in the market. Apple’s launch of smartwatch can be considered exemplary in this case.
Major companies profiled in the report include ODIN, HVMN, Inc., Synbiota, Apple, Thync Global Inc., U.S.A., Moodmetric, Fitbit, Inc., and others. ODIN is leading the market from the front with a 25% share of the global market followed by HVMN, Inc., and Synbiota. 

Segmentation
The global biohacking market can be segmented by type, product, application, and end-users.
Type-wise segmentation of the market includes outside and inside biohacking where the former can reach a valuation of USD 16,142.38 million with the fastest CAGR of 19.72% during the forecast period.
Product-based segmentation includes smart drugs, sensors, strains, and others. With a projected valuation of USD 11,980.71 million in 2023, smart drug segment is leading the market and is expected to rise further with a CAGR of 19.88% during the review period.
Based on applications, the market consists synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing, and others. Synthetic biology segment expects a valuation of USD 3,255.75 million and a CAGR of 19.81% during the same period.
Based on end-users, the market includes pharmaceutical & biotechnology companies, forensic laboratories, and others. Pharmaceutical & biotechnology companies can rise to a valuation of USD 13,882.08 million during the forecast period.

Regional Analysis
Region-specific segmentation of the market spans across the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas, with an expected market valuation of USD 10573.53 million during the forecast period is expected to retain its top position during the forecast period. Its quadruple leap has been ensured by the presence of several biotechnologies and synthetic biology companies. Awareness among the youths also has a lasting impact which consequently propels the market ahead.
Europe holds the second position. But it is the APAC region that is showing stellar progress and is expecting the fastest growth rate of 19.91% during the forecast period. The region has a huge patient pool that requires constant monitoring. Emerging economies such as China and India are also impacting the market by revamping the entire healthcare infrastructure.


 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Cannabidiol (CBD) Market - Trends and Demand By Global Industry Forecast to 2024

Oil made from Cannabidiol (CBD) is called CBD oil. A new report on the global CBD oil market, published by Market Research Future (MRFR), observes that this market could measure growth at 38.45% CAGR between 2018 and 2024. In terms of money value, the market can be worth USD 3782.32 Mn by the end of the forecast period.


The most important market driver for the global CBD oil market growth is rising research funding for cannabinoid research. Legalization of CBD in many countries and the rising occurrence of chronic ailments, along with the complications related to them are also strengthening market growth. Due to rising demand, many new market players are emerging. However, stringent government policies regarding CBD use and the adverse effects associated with cannabis can hinder the market growth. Use of all products derived from cannabis is controversial. Although cannabis-based products include CBD oil have various benefits, the fact about cannabis being an illegal narcotic cannot be ignored. Hence, CBD oil market always faces a lot of restrictions.

Market Segmentation
The global CBD oil market segmentation encompasses application, distribution channel, and type. MRFR’s take on the market surveys various facets of the market in-depth.
The application-based segmentation of this CBD oil market covers cosmetics industry, food industry, pharmaceuticals industry, and others. The cosmetic industry segment holds the largest market share due to the anti-inflammatory and non-psychoactive properties of CBD.
Regarding the distribution channel, the CBD oil market has been segmented into e-commerce websites, hospital pharmacies, medical marijuana dispensaries, and retail pharmacies. By type, the CBD oil market has been segmented into hemp-derived CBD oil and marijuana-derived CBD oil.

Regional Segmentation
A geographical outlining of the global CBD oil market covers the Americas (North America & Latin America), Europe, Asia Pacific, and the Middle East & Africa (MEA).
The Americas dominate the global market due to the increasing consumption of cannabis-based products. North America alone holds the potential of being the largest regional market due to the availability of advanced medical facilities and technological advancement. Most of the major market players in this region are based in USA and Canada. However, a sizable contribution to the market comes from Latin America too. In Latin America, the revenue rises maximum in Argentina, Brazil, and Colombia.
Europe is the second-largest regional market due to the rising awareness about clinical applications of cannabis. The most powerful country-specific markets in Western Europe are France, Germany, Italy, Spain, and the UK.
Asia Pacific region can experience the highest growth during the forecast period due to rapid development in technology, high density of population, improving the healthcare sector. The remarkable country-specific markets in this region are Australia, China, India, Japan, and South Korea.
During the forecast period, the MEA region has been anticipated to witness restricted growth due to adverse effects associated with cannabis, stringent government policies, and the illegal use of marijuana. Some country-specific markets that are better than most of the markets are Egypt, Saudi Arabia, Turkey, and UAE.

Key Players
Big players in the global CBD oil market include Absolute Terps (USA), Aphria Inc. (Canada), Aurora Cannabis (USA), Canopy Growth Corporation (USA), CBD American Shaman (USA), Charlotte's Web Holdings Inc. (USA), Curaleaf Holdings Inc. (USA), CV Sciences Inc. (USA), Emblem Cannabis (Canada), ENDOCA (Netherlands), Folium Biosciences (USA), Freedom Leaf Inc. (USA), Green Roads of Florida LLC (USA), HempLife Today (USA), Kazmira LLC (USA), Medical Marijuana Inc. (USA), MedMen Enterprises Inc. (USA), NuLeaf Naturals (USA), Pharmahemp (Slovenia), and Whistler Medical Marijuana Corporation (Canada).

Latest Industry News
  • Premium cannabis accessories sellers Greenlane Holdings Inc. has forged a partnership with Bouquet for exclusive US distribution of its full-spectrum CBD oil products That includes tinctures and capsules offering a variety of strengths. They are going to offer many other CBD and liquid nicotine products. 27 AUG 2019
Posted by at No comments:
Labels: , ,

Monday, 28 October 2019

World CBD Oil Market Set to Rise at a CAGR of 38.45% Over 2019-2024

CBD Oil Market Highlights
The CBD Oil Market is estimated to be valued at USD 3782.32 Million by 2024 and expected to grow at a CAGR of 38.45% during the forecast period. CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc.


From the past few years, the market for CBD oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil.

CBD Oil Market Players
Market Research Future (MRFR) recognizes the following companies as the key players in the global CBD oil market that includes Aphria Inc. (Canada), Folium Biosciences (US), Freedom Leaf, Inc. (US), Green Roads of Florida, LLC (US), Charlotte's Web Holdings, Inc. (US), ENDOCA (Netherlands), CBD American Shaman (US), CV Sciences, Inc. (US), Medical Marijuana, Inc. (US), Canopy Growth Corporation (US), Aurora Cannabis (US), MedMen Enterprises Inc. (US), Curaleaf Holdings, Inc. (US), Kazmira LLC (US), and others.

CBD Oil Market Segment Analysis
Global CBD oil market has been segmented on the basis of type, and application. On the basis of type, the market has been divided into hemp-derived and marijuana-derived types. The Hemp-derived CBD oil type is holding the major share of the overall CBD oil market. It has been estimated that the hemp-derived segment is growing at the highest CAGR to reach USD 2,092.97 Million by the end of 2024. Most of the legal CBD-based products in the market are hemp-based. According to the 2018 Farm Bill, companies can legally grow, manufacture, possess, and sell hemp-derived CBD products.  
Based on application, the global CBD oil market is segmented into pharmaceuticals, food, cosmetics, and others. Among these segments, the cosmetic industry accounts for the largest market share owing to the anti-inflammatory and non-psychoactive properties of CBD. Moreover, CBD infused beauty products are a major trend these days. For instance, Folium Biosciences, the US-based cannabinoid producer, offers cosmeceuticals which include CBD infused moisturizing relief cream.

CBD Oil Market Regional Analysis
The CBD oil market in the Americas has been segmented into North America and Latin America. The North American market is further divided into the US, Canada, and Mexico. The Americas dominate the global CBD oil market, owing to the increasing consumption of cannabis-based products. According to the World Health Organization (WHO), the consumption of marijuana has an annual prevalence rate of nearly 2.5% of the global population, i.e., approximately 147 million individuals. It is also reported that approximately 22.2 million Americans of 12 years of age and older use cannabis and related products for various reasons. Moreover, cannabis was approved for medicinal use in 28 states of the US, the District of Columbia, Guam, and Puerto Rico as of January 2017. Online availability of cannabis-based products is also boosting the market growth as cannabis consumers prefer to buy online from licensed producers or manufacturers.

Key Findings of the Study:
  • Global CBD oil market is projected to reach 32 Million by 2024 with 38.45% CAGR during the review period of 2019 to 2024
  • The Americas accounted for the largest share due to the increasing consumption of cannabis-based products along with rising legalization of cannabis in the region
  • The hemp-derived CBD oil segment, by type, is projected to reach USD 2,092.97 million by the end of 2024

Latest Trending Reports



About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Sunday, 20 October 2019

Contract Research Organization (CRO) Market Sized, Share, Analysis, Segmentation Overview, Clinical Trial Phase and End Users by 2023


Market Overview
The need to streamline the operations related to manufacturing in the healthcare sector has promoted the growth of the contract research organizations. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is poised to tap into a CAGR of 11.48% in the approaching period.


The presence of big pharmaceutical companies who are growing to be reliant on contract research organizations to meet there requirements is expected to create a favorable scenario for progress. The rising number of research and manufacturing related activities of therapeutic drugs and medical devices is expected to create other beneficial prospects for the development of the contract research organization market in the forthcoming period.

Segment Analysis
The evaluation of the segments in the Contract Research Organization Market is segmented on the basis of the clinical trial phase, region, segment and end users. Based on the segment, the contract research organization market is segmented into clinical development, drug discovery, post-marketing services, and others. The segmentation of the contract research organization market based on the clinical trial comprises of preclinical trials, phase II, phase III, phase I, phase IV, and others. The segmentation of the contract research organization market based on end users comprises of medical devices companies, pharmaceutical/biotechnology companies, academic institutes and others. By region, the contract research organization market comprises of Asia Pacific, Europe, the Middle East, Africa, and the Americas.

Detailed Regional Analysis     
The regional study of the contract research organization market comprises of regions such as Asia Pacific, Europe, the Middle East, Africa, and the Americas. As per the analysis, the Americas region directs the contract research organization market due to a robust healthcare sector and the presence of a vast patient population. Apart from this, altering lifestyles and growing healthcare costs have significantly contributed to the expansion of the market in the Americas region.  Also, the existence of emerging economies like the U.S. and Canada within the region will enhance market growth. The European region is the subsequent prime region in the contract research organization market, which is followed by the Asia Pacific region. The accessibility to funds for research, vast patient population, escalating healthcare expenses, and government backing for research & development is anticipated to impel the market development throughout the forecast period.

The Asia Pacific region is the fastest growing region in global the market owing to the presence of a huge patient population, constantly developing economies like India and China which have growing per capita healthcare expenditures. On the other hand, the Middle Eastern and African region holds the smallest share in the contract research organization market owing to the presence of a poor economy, particularly, in the African region owing to low per capita income and severe government policies.

Top Leading Companies of Contract Research Organization Market 
The noteworthy players in the contract research organization market are QuintilesIMS (U.S.), INC Research LLC (U.S.), Laboratory Corporation of America Holdings. (U.S.), PRA Health Sciences, Inc. (U.S.), Pharmaceutical Product Development, LLC. (U.S.), PAREXEL International Corporation (U.S.) and ICON plc (Europe) among others.

Posted by at No comments:
Labels: ,

Thursday, 17 October 2019

CAGR of +7.8% Growth for Global Medical Oxygen Concentrators Market

Market Highlights
The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea. Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.
Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Segmentation
The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has been divided into the continuous flow and pulse dose.
Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.
By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Key Players
Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.

Regional Analysis
The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.
Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.
The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.
The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.


Most Trendsing Report  Of Healthcare Industry




About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: ,
Location: Rd 155, Lodgepole, NE 69149, USA

Monday, 30 September 2019

Why Human Insulin Growth in Healthcare Industry?

Demand for human insulin also referred to as synthetic insulin is on the rise. Human insulin in the foremost requirement for a diabetic person. The product first came into the picture in 1960s and 1970s but could only get marketed by early 80s. After its commercial launch, the product quickly replaced the existing drug, which was purified form of porcine.  Market Research Future (MRFR) reports the global human insulin market will grow to USD 40 Bn between 2016 and 2021, reflecting a double-digit CAGR. Some of the major drivers of the market include increased level of awareness about diabetes, increased product penetration, growing geriatric population worldwide, expanding diabetic population.


Diabetes is one of the most common disorder in the world and continues to attract robust government initiatives and R&D efforts towards its treatment. Such factors are supporting the market growth. However, stringent regulation, drug approval delays, and high cost of insulin analog are some of bottlenecks for the market. Issues such as side effects and delayed onset of reaction of human insulin are some of the critical challenges that are yet to be fully tackled.

Segmental Overview
MRFR’s report includes comprehensive segmental analysis of the global human insulin market based on type and region.
Based on type, the market has been segmented into traditional human insulin and modern human insulin. The modern human insulin segment is further segmented into premixed human insulin, rapid acting human insulin and long acting human insulin. The tradition human insulin segment is further sub-segment into intermediate acting human insulin and short acting human insulin. In terms of value, the modern human insulin segment accounts for a relatively larger market share.

Global Human Insulin Market: Regional Segmentation
Key regions covered in MRFR’s report include North America, Asia and Europe. North America holds the dominant position in the global human insulin market. The primary growth driver of the market in North America is the high prevalence of diabetes and obesity. In the forthcoming years demand for human insulin is expected to grow further in countries such the U.S., Canada, and Mexico. Prevalence of diabetes is widespread in these countries; the disease continues to be major public health issues in the region. Rising number of elderly population and sedentary lifestyle is also linked with the increase diabetes prevalence. North America is likely to retain its top position over 2021.
Europe hold the second sport in terms of value. Additionally, the market in Europe is expected to exhibit a steady growth during the forecast period. Presence of a robust healthcare system is providing an impetus to the market in Europe. At the same time, a well-defined framework for public welfare in EU countries is auguring well for the human insulin market.
Meanwhile, the market in Asia is touted to exhibit the strongest growth during the forecast period. Increased healthcare spending, and rising prevalence of diabetes are two the prominent factors driving the market growth in Asia. Countries such as Chin and India are witness tremendous expansion of the domestic healthcare industry. These countries represent high-growth markets for human insulin. Furthermore, increased investment in R&D activities along with introduction of favourable government policies in Asia is supporting the market growth in the region. There has a sharp rise in type 2 diabetes prevalence in various countries in region.  

Competitive Landscape  
Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Merck & Co. (U.S.), Bristol-Myers Squibb Company (U.S.), Oramed Pharmaceuticals, Inc. (Israel), Adocia (France.), GlaxoSmithKline Plc (U.K.), Biocon Ltd. (India), Novo Nordisk A/S (Denmark) and Julphar (UAE) are some of the leading profiled in MRFR’s report.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , , , ,
Subscribe to: Posts (Atom)